This page identifies instances in which lupron and/or its manufacturer is discussed in newspaper stories, magazine articles, TV news or shows, or in articles, blogs, stories and posts on the internet. The majority of these stories discuss the risks of Lupron. Instances of the censoring of Lupron information will also be included here.

*********************************************************************

*********************************************************************

12-12-19 ... CALL TO ACTION for Lupron Victims:

Today, more than at any other time in the past, a variety of sources are exerting noteworthy pressure upon a number of governmental agencies concerning the risks of Lupron, which should have the effect of putting Lupron into a focus it has managed to evade up till now. Therefore, it has become vitally important for Lupron victims to report their adverse events to the FDA so that a more comprehensive picture of Lupron's damage can become evident. (It would also be very helpful for Lupron / GnRHa victims to participate in the "Post-Drug Syndrome Survey - further discussed below.)

Historically only 1% to 10% of adverse events are ever reported to the FDA (see page 6 here). Thus, it can be assumed the number of Lupron adverse events reported to FDA have been woefully inadequate, and are *not* a true representation of the actual number of affected individuals nor of the extent of adverse effects. But you can change this situation by filing a MedWatch Report. It is not necessary to have a physician or nurse file a report -- anyone can report their own adverse effects directly to the FDA. And if you have filed a report in the past but since then have developed new symptoms and/or diseases, you can file another MedWatch Report to provide those additional developments.

In light of the pressures being brought to bear to expose Lupron's risks, now is the time to demonstrate by more authentic numbers the real-life horrific effects of Lupron. Here is an elaboration of some of these 'pressures' (and see links in Left column for further information on these 2019 stories):

---- Dr. David Redwine is 'cobbling' some 'things' together (see "Watch for Developments", below). And in Dr. Redwine's Nov. 25, 2019 Facebook post "WHAT CAN PATIENTS DO TO HELP WITH THE LUPRON ISSUE?", he initiated this renewed call for Lupron victims to file a MedWatch report. Dr. Redwine's Nov. 25th post also states the following:

"Also [in addition to filing a MedWatch report], it would be appropriate to inform your elected federal Congresspersons and Senators of your concerns and that early (1980's) evidence of damage to ovarian function was hidden from physicians. Feel free to send the link to my Facebook review [It goes into scientific details about damage to ovarian function that was kept secret -- https://www.facebook.com/david.redwine.90/posts/2315240045268343]. Current reports of adverse events will merge with an unseen, oncoming rising tide and help float the boat. Contributions from patients experiencing long-term problems are very important."

---- Lupron Victims Hub sent an inquiry to FDA in September, requesting the FDA address the issue of FDA's 1990 approval of Lupron Depot 3.75 mg being based upon its review of clinical trial data which contained fraudulent data and altered outcomes.

---- The Kelsey Coalition (a group of parents concerned with the risks of Lupron/GnRHas, testosterone, estrogen, and sex-reassignment surgery in the transgender population) has petitioned the Surgeon General to take action; has called for an investigation into the "unethical" NIH GnRHa study in the transgender population; and has called for a moratorium of the study with the Office for Human Research Protections. They have also launched their 'First, Do No Harm Campaign' to educate medical professionals on the risks of 'treatment'.

---- Texas Rep. Chip Roy has requested the Attorney General and the Directors of the NIH and the Office of National Drug Control Policy "conduct a federal study on individuals who undergo ... hormone treatment before the age of 18."

---- The governor of Texas has called for an investigation into the Younger case.

---- Continued media coverage (internet stories & TV coverage) of Lupron's negative effects.

---- Plaintiff Terry Paulsen survived several motions to dismiss her case, and so she continues forward with her protracted litigation v. Abbott and AbbVie. Terry's case and Lupron's negative effects have been featured on Atlanta, Georgia's WSB-TV News, which also started a Facebook page. Within 24 hours of the news story, the station had heard from hundreds of women throughout the country reporting negative effects from Lupron. (See below for links.)

---- Numerous Facebook 'Lupron Victim Groups' flourish, all detailing horrific stories and all calling for action and acknowledgment of Lupron's adverse effects.

---- A multi-drug "Post-Drug Syndrome Survey" was launched this year by PropeciaHelp.com, and Lupron/GnRHas are among the drugs being surveyed. Data is still being collected, therefore this study's final results remain pending. Regrettably, there have been very few Lupron participants in this survey, and so no data can be as yet analyzed. I would urge participation in this survey so that data can be collected. For further background and information on this survey, see here and here. A considerable number of people who've experienced health problems following the use of antidepressants, finasteride, and isotretinoin have participated in this survey, and I would encourage lupron victims to view the data generated by their participation (see here). It could be very helpful if Lupron victims were also able to demonstrate quantifiable data such as this.

And concerning MedWatch reports, consider the following:

Think about the numbers of Lupron victims that have been identified since the 1980s, within lawsuits, within the many now-defunct internet message boards and groups, and in the multitudes of print and televised coverage - and then add to this volume today's magnitude where Lupron victims post their stories in the full spectrum of social media platforms, and in the many internet stories, and in medication and drug review websites, and in various petitions, and in legal and pharmaceutical forum postings, etc.

If every internet poster who has ever written a message about their adverse Lupron experience were to also file a MedWatch report, the FDA would be overwhelmed by a staggering number of reports. Any subsequent attempt to ignore, deny or diminish Lupron's negative effects would become difficult in light of such a flood of adverse event reports. And if this should be coupled with participation by Lupron victims in the multi-drug "Post-Drug Syndrome Survey", our 'case' for the need for acknowledgment and medicolegal advocacy would become self evdent.

Please try to help make this happen. As Dr. Redwine said "Contributions from patients experiencing long-term problems are very important."

Thank you.

MedWatch Form ... "Post-Drug Syndrome Survey"

*********************************************************************

*********************************************************************

Watch for developments on David Redwine MD's Facebook page.

For example, Dr. Redwine's Nov. 17,2019 post:

"FRAUD IN THE DEVELOPMENT OF LUPRON? ... (discussing Lupron Study M84-042):

"Estradiol levels were checked in 8 patients at one year after stopping Lupron. Ignoring for a moment that 8 patients is a very small number, the estradiol levels at ONE YEAR after stopping Lupron were lower than baseline in 88% of patients ... One patient had an estradiol level of 28 which is essentially menopausal. ...

These 8 patients [] constitute the only evidence that estrogen levels were checked by the manufacturer long after Lupron was discontinued that I found in my review of thousands of pages of in-house studies. 8 patients hidden deep in the data but not discussed in the medical journal publication coming out of that in-house study. 8 patients with objective laboratory evidence suggesting long-term ovarian dysfunction in a substantial fraction of patients exposed to the drug. 8 patients whose estradiol decline should have been a sign to get more information on what happens to ovarian function long after Lupron. I suspect that there is more evidence about estradiol that was not produced in discovery during Klein v Abbott. ...

For 30 years the manufacturer of Lupron has hidden the facts that Lupron therapy is followed by ovarian dysfunction or ovarian failure in a substantial fraction of those receiving it and that it has no evidence in thousands of pages of in-house studies that ovarian function recovers in that fraction. Physicians are unaware of this fact and so cannot obtain informed consent from any patient for this reason." 

*********************************************************************-

-------------------------------------------------------------------------------------------------

MULTI-PART INVESTIGATIONS and 'SERIES' on Lupron:

-------------------------------------------------------------------------------------------------

WSB-TV, Atlanta, Georgia's 'Channel 2, Action News':

10-29-18: Part 1 - 5 pm ... 'Action News' investigates Lupron (also posted on YouTube)

10-29-18: Part 2 - 6 pm ... 'Action News' investigates Orilissa (with more Lupron coverage)

10-30-18: Part 3 - 5 pm ... 'Action News' investigates Lupron

Within 24 hours, WSB-TV had heard from hundreds of women throughout the country reporting negative effects from Lupron.

To summarize these 3 stories, the series began with Terry Paulsen, her disability and her current lawsuit, along with interviews of Terry's legal counsel, a medical expert, and another Lupron victim. Brooklyn Harbin, formerly athletic, described her back pain and how she needed a wheelchair in the 5th grade after taking Lupron for precocious puberty.

The follow-up 10-30-18 story (Part 3) interviewed 2 women - one who reported experiencing no negative effects ("maybe I was lucky"), and another woman, Sheila Reed, reported that since her Lupron injection 4 months ago she has had no feeling in her legs, is unable to walk, has slurred speech, a clenched hand, and her mouth droops at times. Sheila said "Had a shot and can't walk."

All who have suffered from exposure to this drug are encouraged to watch Part 1, Part 2, and Part 3, and to consider commenting at the TV station's Facebook page on how Lupron has affected you and your life.

-------------------------------------------------------------------------------------------------

HormonesMatter.com 6-part series on Lupron (focus on pediatric population):

03-01-17 - Part 1: Lupron for Precocious Puberty - Parents and Patients Speak Out

03-09-17 - Part 2: Lupron for Precocious Puberty and Beyond - Two Decades of Regulatory Silence

03-15-17 - Part 3: Lupron and Reproductive Injury

04-05-17 - Part 4: How Long Does Lupron or Its Metabolites Circulate? No One Really Knows.

04-18-17 - Part 5: The Lupron Money Trail

05-31-17 - Part 6: They Say Lupron is Safe

-------------------------------------------------------------------------------------------------

ABC Las Vegas KTNV 9-part lupron Series:

10-30-09: Part 1 ... Lupron - "Overpriced Poison?"

11-09: Part 2 ... Lupron - "Overpriced Poison?"

12-02-09: Part 3 ... The case for recalling Lupron : transcript Part 3 - The case for recalling Lupron

06-22-10: Part 4 ... 'FDA Reviewing Safety of Lupron Depot'

08-01-11: Part 5 ... Trial for 'Overpriced Poison' Lupron begins in federal court

08-10-11: Part 6 ... Lupron verdict in Las Vegas trial deals blow to victims

08-12-11: Part 7 ... Lupron Trial - Plaintiff Outraged by Severe Injustice

10-24-13: Part 8 ... AMICUS Needed at US Supreme Court

02-11-19: Part 9 ... Lupron Story Preview

02-11-19: Part 10 ... More women come forward with complaints about Lupron's side effects

------------------------------------------------------------------------------------------------

'REDFLAGES Weekly' 7-part investigation of lupron, by Nicholas Regush

1.  January 19, 2002.  Lynne’s Story: A Preamble to RFW’s Lupron Investigation

2. January 26, 2002. Living Hell: Women Speak Out About Lupron.

3.  February 2, 2002.  False Promises, Ignorance And Fast-Paced Medicine. A Doctor Speaks Out Against Lupron.

4.  February 2, 2002. Are Persistent Lupron-Related Side-Effects Due To A Malfunctioning Pituitary Gland?

5.  March 11, 2002. Where’s The Science?  Lupron, Infertility, And Women As Guinea Pigs.

6.  April 10, 2002.  Lupron And Fertility Treatment:  One Woman’s Agonizing Odyssey.

7.  May 17, 2003. The Lupron Story.  RFD [RedFlagsDaily] Report.  (special thanks to Barbara Lewis and RedFlagsDaily.com for permission to reprint this RFD Report)

------------------------------------------------------------------------------------------------

Boston FOX 25 TV News' 1999 2-part investigation of lupron:

05-24-99: "Risk or Remedy?" Part 1 (transcript)

11-29-99: "Dangers of Lupron" Part 2 (summary)

-------------------------------------------------------------------------------------------------

See Photo of March 1999 anti-lupron rally in Boston.

-------------------------------------------------------------------------------------------------

Boston Herald's 3-part lupron investigative reports:

08-22-99: Medical miracle turns nightmare

08-23-99: "Women seek answers in drug's suspected side effects"

08-24-99: "Women outraged over drug's ill effects"

-------------------------------------------------------------------------------------------------

Boston Globe's 2-part fertility treatment investigation (involving lupron):

08-04-96: Boston Globe, page 1: "What Price Pregnancy - The Painful Quest for Fertility", Part 1, by Dolores Kong

08-05-96: Boston Globe, page 1: "What Price Pregnancy" - Part 2, by Dolores Kong

08-04-96 Boston Globe: RESOLVE receives hundreds of thousands of dollars from fertility drug companies (Note: link removed - screenshot can be seen here)

**********************************************************************

TAKE NOTE of investigative journalist Sharyl Attkinsson's generalized statements:

Attkinsson said "it is more and more difficult for investigative reporters to get their stories published or on the air because of the trouble it may cause." (03-21-14)

And in her new book "Stonewalled: My Fight for Truth Against the Forces of Obstruction, Intimidation, and Harassment in Obama's Washington", Sharyl Attkinsson states: "Congress has gotten in some respects like some in the media, where according to members themselves and their staff, there is not the appetite to do the hard-nosed investigations and oversight that they used to do." (11-06-14)